SEC 13F Intelligence

Orbimed Advisors LLC / CAI

Orbimed Advisors LLC’s Caris Life Sciences Inc Position

Does Orbimed Advisors LLC own Caris Life Sciences Inc (CAI)? Yes — 2.81M shares worth $50M (+0.99% of its 13F portfolio) as of Q1 2026, down from 3.12M shares the prior filed quarter.

Position Value
$50M
Q1 2026
Shares
2.81M
% of Portfolio
+0.99%
Quarters Held
4
currently held

Position History CAI

Reported value by quarter
Q2 ’25: $81MQ2 ’25Q3 ’25: $92MQ3 ’25Q4 ’25: $84MQ4 ’25Q1 ’26: $50MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.81M$50M+0.99%
Q4 20253.12M$84M+1.72%
Q3 20253.03M$92M+2.16%
Q2 20253.03M$81M+2.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of CAI.